Kexing Biopharm
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
- Medical device or technology
Kexing Biopharm is an international, innovation-driven biopharma company focused on the development, manufacturing, and commercialization of recombinant proteins, antibodies, nucleic acid drugs, and microbiome therapeutics. With a product portfolio of 22 approved drugs and a growing pipeline addressing autoimmune, oncology, viral, metabolic, and degenerative diseases, Kexing leverages its proprietary platforms (KX-FUSION, KX-BODY, K’Exosome, and more) for breakthrough innovation. With 6 global subsidiaries and commercial presence in over 70 countries, Kexing Biopharm is committed to becoming a global leader in high-quality biologics, delivering AI-powered antibody therapies for the world’s most difficult-to-treat diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}